Singapore markets close in 2 hours 14 minutes
Straits Times Index
3,322.08 -4.20 (-0.13%) Nikkei
39,667.07 +493.92 (+1.26%) Hang Seng
18,139.67 +66.77 (+0.37%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,535.25 +420.80 (+0.69%) CMC Crypto 200
1,278.79 -4.99 (-0.39%)
Cyclacel Pharmaceuticals, Inc. (CYCC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.6700 |
| Open | 1.6700 |
| Bid | 1.5500 x 100 |
| Ask | 1.6300 x 100 |
| Day's range | 1.5500 - 1.7400 |
| 52-week range | 1.3000 - 13.2000 |
| Volume | |
| Avg. volume | 876,103 |
| Market cap | 2.327M |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Cyclacel Pharmaceuticals (CYCC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- GuruFocus.com
Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Insights into CYCC's financial health and strategic advancements in oncology research during the first quarter of 2024.
- Simply Wall St.
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future
Cyclacel Pharmaceuticals, Inc. ( NASDAQ:CYCC ) is possibly approaching a major achievement in its business, so we would...
© 2024 Yahoo. All rights reserved.